Adult | Age
Item
adult patients, >/= 18 years of age
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Chronic Lymphocytic Leukemia
Item
patients with chronic lymphocytic leukaemia
boolean
C0023434 (UMLS CUI [1])
First line treatment
Item
patients receiving 1st line therapy
boolean
C1708063 (UMLS CUI [1])
Second line treatment | First line treatment Disease Response | Recurrent disease
Item
patients receiving 2nd line therapy. this will include patients who previously have responded well to 1st line therapy (relapse was >12 months after finishing the 1st line therapy) and are receiving the same therapy again
boolean
C1710038 (UMLS CUI [1])
C1708063 (UMLS CUI [2,1])
C1704632 (UMLS CUI [2,2])
C0277556 (UMLS CUI [3])
Therapeutic procedure Discontinued | Status post First line treatment Course Quantity | Status post Second line treatment Course Quantity
Item
within the past three months, patients whose treatment has been stopped after 2-3 cycles of 1st or 2nd line therapy and who have not received any further therapies
boolean
C0087111 (UMLS CUI [1,1])
C1444662 (UMLS CUI [1,2])
C0231290 (UMLS CUI [2,1])
C1708063 (UMLS CUI [2,2])
C0750729 (UMLS CUI [2,3])
C1265611 (UMLS CUI [2,4])
C0231290 (UMLS CUI [3,1])
C1710038 (UMLS CUI [3,2])
C0750729 (UMLS CUI [3,3])
C1265611 (UMLS CUI [3,4])
First line treatment Course Ordinal number | Second line treatment Course Ordinal number
Item
patients receiving their 3rd, 4th, 5th or 6th cycle of 1st or 2nd line therapy
boolean
C1708063 (UMLS CUI [1,1])
C0750729 (UMLS CUI [1,2])
C0439080 (UMLS CUI [1,3])
C1710038 (UMLS CUI [2,1])
C0750729 (UMLS CUI [2,2])
C0439080 (UMLS CUI [2,3])
Treatment completed | Patient's condition stable | Status post Therapeutic procedure Month Quantity
Item
patients who have completed therapy, are considered stable and are between 3-12 months post therapy
boolean
C0580352 (UMLS CUI [1])
C1282982 (UMLS CUI [2])
C0231290 (UMLS CUI [3,1])
C0087111 (UMLS CUI [3,2])
C0439231 (UMLS CUI [3,3])
C1265611 (UMLS CUI [3,4])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status 0-1
boolean
C1520224 (UMLS CUI [1])
Disease Clinical Significance | Exception Chronic Lymphocytic Leukemia | Exception Comorbidity lymphocytic chronic | Condition Interferes with Study Subject Participation Status | Condition Affecting Research results | Substance Use Disorders
Item
clinically significant disorder (other than chronic lymphocytic leukaemia and chronic lymphocytic comorbidities) or any other condition, including alcohol or drug abuse, which may interfere with study participation or affect study conclusions
boolean
C0012634 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0023434 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0009488 (UMLS CUI [3,2])
C2939172 (UMLS CUI [3,3])
C0205191 (UMLS CUI [3,4])
C0348080 (UMLS CUI [4,1])
C0521102 (UMLS CUI [4,2])
C2348568 (UMLS CUI [4,3])
C0348080 (UMLS CUI [5,1])
C0392760 (UMLS CUI [5,2])
C0683954 (UMLS CUI [5,3])
C0038586 (UMLS CUI [6])
Mental handicap | Mental disorders | Legal capacity Lacking | Legal capacity Limited
Item
mental disability or significant mental illness, legal incapacity or limited legal capacity
boolean
C1306341 (UMLS CUI [1])
C0004936 (UMLS CUI [2])
C0683673 (UMLS CUI [3,1])
C0332268 (UMLS CUI [3,2])
C0683673 (UMLS CUI [4,1])
C0439801 (UMLS CUI [4,2])
Comorbidity Severe Affecting Quality of life
Item
current high degree of comorbid burden that might affect the accuracy of the quality of life data
boolean
C0009488 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0392760 (UMLS CUI [1,3])
C0034380 (UMLS CUI [1,4])